These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 23443947

  • 1. Technical effects of adding 1 % lidocaine to technetium sulfur colloid for sentinel lymphatic mapping in early breast cancer: analysis of data from a double-blind randomized controlled trial.
    Arciero CA, Henry LR, Howard RS, Peoples GE, Bilchik AJ, Avital I, Buckenmaier Iii CC, Stojadinovic A.
    Ann Surg Oncol; 2013 Aug; 20(8):2548-55. PubMed ID: 23443947
    [Abstract] [Full Text] [Related]

  • 2. Standard versus pH-adjusted and lidocaine supplemented radiocolloid for patients undergoing sentinel-lymph-node mapping and biopsy for early breast cancer (PASSION-P trial): a double-blind, randomised controlled trial.
    Stojadinovic A, Peoples GE, Jurgens JS, Howard RS, Schuyler B, Kwon KH, Henry LR, Shriver CD, Buckenmaier CC.
    Lancet Oncol; 2009 Sep; 10(9):849-54. PubMed ID: 19664956
    [Abstract] [Full Text] [Related]

  • 3. Identification of sentinel lymph node in stage I-II breast cancer with lymphoscintigraphy and surgical gamma probe: comparison of Tc-99m MIBI and Tc-99m sulfur colloid.
    Arcan P, Ibis E, Aras G, Cam R, Küçük NO.
    Clin Nucl Med; 2005 May; 30(5):317-21. PubMed ID: 15827399
    [Abstract] [Full Text] [Related]

  • 4. Use of low-dose technetium Tc 99m sulfur colloid to locate sentinel lymph nodes in melanoma of the head and neck: preliminary study.
    Rasgon BM.
    Laryngoscope; 2001 Aug; 111(8):1366-72. PubMed ID: 11568570
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic accuracy of sentinel node identification is maintained with the addition of local lidocaine and subareolar radioactive colloid injection.
    Stearns V, Blackford A, Kessler J, Sbaity E, Habibi M, Khouri N, Lee CS, May E, Jeter S, Sahebi C, Shehata C, Tarpinian K, Jacobs L, Eisner D.
    Breast Cancer Res Treat; 2015 Apr; 150(3):589-95. PubMed ID: 25788225
    [Abstract] [Full Text] [Related]

  • 6. Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: Results from a randomized, blinded clinical trial.
    Unkart JT, Hosseini A, Wallace AM.
    J Surg Oncol; 2017 Dec; 116(7):819-823. PubMed ID: 28695567
    [Abstract] [Full Text] [Related]

  • 7. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
    Babiera GV, Delpassand ES, Breslin TM, Ross MI, Ames FC, Singletary SE, Kuerer HM, Feig BW, Meric-Bernstam F, Hunt KK.
    Clin Nucl Med; 2005 Jan; 30(1):11-5. PubMed ID: 15604959
    [Abstract] [Full Text] [Related]

  • 8. Radio-guided sentinel lymph node biopsy using periareolar injection technique for patients with early breast cancer.
    Yen RF, Kuo WH, Lien HC, Chen TH, Jan IS, Wu YW, Wang MY, Chang KJ, Huang CS.
    J Formos Med Assoc; 2007 Jan; 106(1):44-50. PubMed ID: 17282970
    [Abstract] [Full Text] [Related]

  • 9. Failure predictors of the sentinel lymph node in patients with breast cancer using Tc-99m sulfur colloid and periareolar injection.
    Pritsivelis C, Garcia Mendonça CA, Pinheiro Pessoa MC, Coelho-Oliveira A, Gutfilen B, Barbosa Da Fonseca LM.
    Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):189-93. PubMed ID: 17420718
    [Abstract] [Full Text] [Related]

  • 10. Intraoperative radioisotope injection for sentinel lymph node biopsy.
    Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Smith M, Klimberg VS.
    Ann Surg Oncol; 2008 Nov; 15(11):3216-21. PubMed ID: 18777194
    [Abstract] [Full Text] [Related]

  • 11. Comparison between one day and two days protocols for sentinel node mapping of breast cancer patients.
    Ali J, Alireza R, Mostafa M, Naser FM, Bahram M, Ramin S.
    Hell J Nucl Med; 2011 Nov; 14(3):313-5. PubMed ID: 22087458
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of radiotracer for sentinel lymph node mapping in breast cancer optimizes staging independent of site of administration.
    Kesmodel SB, Canter RJ, Terhune KP, Bauer TW, Mick R, Rosato EF, Spitz FR, Fraker DL, Alavi A, Czerniecki BJ.
    Clin Nucl Med; 2006 Sep; 31(9):527-33. PubMed ID: 16921275
    [Abstract] [Full Text] [Related]

  • 14. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience.
    Mudun A, Sanli Y, Ozmen V, Turkmen C, Ozel S, Eroglu A, Igci A, Yavuz E, Tuzlali S, Muslumanoglu M, Cantez S.
    Clin Nucl Med; 2008 Apr; 33(4):262-7. PubMed ID: 18356664
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
    Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS.
    Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
    [Abstract] [Full Text] [Related]

  • 17. Pain ratings by patients and their providers of radionucleotide injection for breast cancer lymphatic mapping.
    Radowsky JS, Baines L, Howard RS, Shriver CD, Buckenmaier CC, Stojadinovic A.
    Pain Med; 2012 May; 13(5):670-6. PubMed ID: 22536858
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients?
    Chung A, Yu J, Stempel M, Patil S, Cody H, Montgomery L.
    Ann Surg Oncol; 2008 Oct; 15(10):2728-33. PubMed ID: 18688679
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.